ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts (2017) 50 MC2.1 | DOI: 10.1530/endoabs.50.MC2.1

Neuroendocrine tumours and the set up in the UK

John Newell-Price

University of Sheffield, Sheffield, UK.

Patients with neuroendocrine tumours require co-ordinated multidisciplinary and multimodal management, with appropriate referral pathways and access to timely expert care. This is exemplified by the European Neuroendocrine Tumour Society (ENETS) Centres of Excellence (CoE). There are forty CoE in Europe, ten of which are in the UK. The bar to achieve CoE status is set high, and the standards used for the audit assessments are appropriate to deliver best care even where centre status has not been sort or achieved. The UK and Ireland Neuroendocrine Tumour Society (UKINETS) and NET patient Foundation work closely with centres and aim to drive up standards across the UK. Overall, the UK is well-served by the existing CoE centres and other centres, and the collaborative model of regional hubs with local spokes providing excellent care and pathways in many regions. Such a model has been proposed by the CRGs for Specialised Endocrinology and Specialised Hepatobilary Disease as an optimum template for NHSE commissioning, and can serve as a template for specialised services in general.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts